InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
QUANTI-Blue™ | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
RAW-Blue™ Cells | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
Pam3CSK4 Biotin | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
Normocin® - Antimicrobial Reagent | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
Zeocin® | Spatial organization of FcγR and TLR2/1 on phagosome membranes differentially... | 2021 | Sci Rep. | Li W. et al. | DOI: 10.1038/s41598-021-92910-9 |
FSL-1 | Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role f... | 2021 | Cell Rep. | Marks K.E. et al. | DOI: 10.1016/j.celrep.2021.109303 |
Pam3CSK4 | Toll-like receptor 2 induces pathogenicity in Th17 cells and reveals a role f... | 2021 | Cell Rep. | Marks K.E. et al. | DOI: 10.1016/j.celrep.2021.109303 |
Imiquimod VacciGrade™ (R837) | Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Respo... | 2021 | Front Neurosci. | Storgaard Dieu R. et al. | DOI: 10.3389/fnins.2021.685645 |
ODN 1585 VacciGrade™ | Central Nervous System-Endogenous TLR7 and TLR9 Induce Different Immune Respo... | 2021 | Front Neurosci. | Storgaard Dieu R. et al. | DOI: 10.3389/fnins.2021.685645 |
THP1-Blue™ NF-κB Cells | Anti-Inflammatory Potential of Simvastatin Loaded Nanoliposomes in 2D and 3D ... | 2021 | Nanomedicine | Rakshit M. et al. | DOI: 10.1016/j.nano.2021.102434 |
Normocin® - Antimicrobial Reagent | Anti-Inflammatory Potential of Simvastatin Loaded Nanoliposomes in 2D and 3D ... | 2021 | Nanomedicine | Rakshit M. et al. | DOI: 10.1016/j.nano.2021.102434 |
Normocin® - Antimicrobial Reagent | Targeted Chemotherapy of Glioblastoma Spheroids with an Iontronic Pump. | 2021 | Adv Mater Technol. | Waldherr L. et al. | DOI: 10.1002/admt.202001302 |
Anti-CD20 (Rituximab biosimilar - IgG1 isotype) | Development of a Macrophage-Based ADCC Assay. | 2021 | Vaccines (Basel). | Uccellini M.B. et al. | DOI: 10.3390/vaccines9060660 |
Anti-CD20 (Rituximab biosimilar - IgG2 isotype) | Development of a Macrophage-Based ADCC Assay. | 2021 | Vaccines (Basel). | Uccellini M.B. et al. | DOI: 10.3390/vaccines9060660 |
Anti-CD20 (Rituximab biosimilar - mIgG1 isotype) | Development of a Macrophage-Based ADCC Assay. | 2021 | Vaccines (Basel). | Uccellini M.B. et al. | DOI: 10.3390/vaccines9060660 |
Anti-CD20 (Rituximab biosimilar - mIgG2a isotype) | Development of a Macrophage-Based ADCC Assay. | 2021 | Vaccines (Basel). | Uccellini M.B. et al. | DOI: 10.3390/vaccines9060660 |
Anti-CD20 (Rituximab biosimilar - IgG3 isotype) | Development of a Macrophage-Based ADCC Assay. | 2021 | Vaccines (Basel). | Uccellini M.B. et al. | DOI: 10.3390/vaccines9060660 |
Recombinant anti-CD20 antibody (Rituximab biosimilar - IgG1NQ isotype) | Development of a Macrophage-Based ADCC Assay. | 2021 | Vaccines (Basel). | Uccellini M.B. et al. | DOI: 10.3390/vaccines9060660 |
Anti-HER2 (Trastuzumab biosimilar - IgG1 isotype) | Development of a Macrophage-Based ADCC Assay. | 2021 | Vaccines (Basel). | Uccellini M.B. et al. | DOI: 10.3390/vaccines9060660 |
THP1-Dual™ Cells | Mechanism of Nucleic Acid Sensing in Retinal Pigment Epithelium (RPE): RIG-I ... | 2021 | J Immunol Res. | Schustak J. et al. | DOI: 10.1155/2021/9975628 |